Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Salt Hydrogel for Prevention and Treatment of Radiation-Induced Oral Mucositis and Taste Disorders
ChiCTR2600121292Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Stomatology, Sichuan University
- Start
- Mar 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lithium carbonate in oral mucositis (OM), Gustatory Dysfunction and xerostomia (7 arms), sponsored by West China Hospital of Stomatology, Sichuan University. Primary endpoints: Hydrogel-related adverse events (Phase I), Hydrogel-related adverse events (Phase II) and 2 more. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
lithium carbonate
03
Conditions
oral mucositis (OM)Gustatory Dysfunctionxerostomia
Beyond the preview
Go deeper on ChiCTR2600121292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121292.